MMedication Read More Novo’s Wegovy pill improves weight loss after switch from injectionsSeptember 30, 2026 People who switched from obesity injections to Novo‘s new Wegovy pill continued to lose weight after three months,…
HHealthcare Read More Novo Nordisk CEO on rebuilding investor trust after backlashSeptember 24, 2026 Novo Nordisk CEO Maziar Mike Doustdar waits for the start of the pharmaceutical company’s annual general meeting in…
HHealthcare Read More Novo Nordisk rebrands to ‘Novo’ under CEO Mike DoustdarSeptember 14, 2026 People walk past a sign for Novo Nordisk’s annual general meeting at the entrance to the venue in…
BBusiness Read More Novo Nordisk sued by shareholders over weight-loss drug: What to knowJuly 29, 2026 A federal judge on Tuesday allowed parts of that lawsuit to move forward, finding that investors had plausibly…
HHealth Read More Novo Nordisk stock rises after Wegovy recommended by UK’s drug price regulatorApril 1, 2026 Michael Siluk | UCG | Universal Images Group | Getty Images Novo Nordisk rose as much as 4%…
HHealthcare Read More These 4 charts show the scale of Novo Nordisk’s woesFebruary 25, 2026 Novo Nordisk was the first company to make a GLP-1 drug for weight loss and became Europe’s most…